1d agoDevan, founder of rnav8bio, says NewLimit's cellular reprogramming relies on mRNA and lipid nanoparticle delivery of transcription factorsThe transcription factor payloads are discovered through iterative screens.SentimentSentimentPos100%Neg0%Users express optimism about NewLimit's liver aging reversal trial because it could deliver healthy young liver function as a first step toward broader longevity benefits.1 comment with sentiment. View comments.